ESTROGENS DECREASE GAMMA-RAYS INDUCED SENESCENCE AND MAINTAIN CELL CYCLE PROGRESSION IN BREAST CANCER CELLS INDEPENDENTLY OF P53.
PERSISTENT USE OF FALSE CELL LINES.
Main menu


Marc Lacroix - List of publications - Click here

AN UPDATE ON TUMOR SUPPRESSOR GENES IN BREAST CANCER.


Marc Lacroix
in Tumor Suppressor Genes
Nova Sciences Publishers, ISBN 1-60021-693-5
Editor: Katherine R. Polinsky (2007) 177-251

   Breast cancer is characterized by the accumulation of genetic alterations, including point mutations and loss of entire DNA regions (“loss of heterozygosity” or LOH). Among genes that are affected by such events, the “tumor suppressor genes” (TSGs) have a peculiar interest since they often occupy pivotal positions in regulatory networks that control the cell cycle and/or encompass various signal transduction cascades. While a number of genes have been suggested as candidate TSGs in breast cancer, only a few of them have been confirmed in this status. They include TP53, BRCA1, BRCA2…and are mainly involved in the control of DNA repair, cell proliferation, apoptosis and signaling. Some TSGs are linked to familial (hereditary) forms of breast cancer. The exact definition of what is a TSG is still debated. Recently, genes not affected by mutation or even LOH, but occasionally methylated have been considered as TSGs.

Genes discussed:

On chromosome 1: CLCA2, DIRAS3 (ARHI, RHOI, NOEY2), LPHH1, TTC4, RAD54L (RAD54), FABP3 (MDGI), RUNX3 (CBFA3, AML2), PRDM2 transcript 1 (RIZ transcript 1), SFN (14-3-3s)

On chromosome 3: ROBO1 (DUTT1), PTPG (PTPRG); FHIT (FRA3B, included), PB1 (BAF180), RASSF1 transcript A, RBM5 (LUCA-15, H37), TUSC4 (NPRL2), TMEM158 (RIS1), SEMA3B, TGFBR2 (HNPCC6), APRG1 (C3ORF35), RARB transcript 2, VHL, ATR (FRP1)

On chromosome 4: SLIT2, PRDM5, HPGD (PGDH1)

On chromosome 5: DAB2 (C9), APC, IRF1

On chromosome 6: PLAGL1 (ZAC, LOT1), LATS1 (WARTS), IGF2R (MPRI)

On chromosome 7: ST7 (TSG7, RAY1, FAM4A1, HELG)

On chromosome 8: SFRP1 (FRP), DLC1 (ARHGAP7), BNIP3L, RHOBTB2 (DBC2), LZTS1 (FEZ1, F37), MTUS1 (ATIP), MCPH1 (BRIT1), ST18

On chromosome 9: CDKN2A (p16INK4A, p14ARF), SYK, DAB2IP (AIP1), TSC1

On chromosome 10: PTEN (MMAC1), PDCD4, MGMT

On chromosome 11: WT1, TSG101, CDKN1C (BWS), CST6, IGSF4 (TSLC1, ST17, NECL2), ATM, LOH11CR2A (BCSC1)

On chromosome 12: CCND2

On chromosome 13: LATS2, BRCA2 (FANCD1), RB1, ARL11 (ARLTS1)

On chromosome 15: RAD51 (RECA)

On chromosome 16: TSC2, CYLD, CTCF, CDH1, TERF2 (TRF2), TERFIP, FBXL8, LRRC29, ATBF1, WWOX, FBXO31, CBFA2T3 transcript B (MTG16), CPNE7, CDK10 (PISSLRE), FANCA, GAS11, C16ORF3

On chromosome 17: MAP2K4 (SERK1, SEK1, PRKMK4, MEK4), GABARAP, TP53, HIC1, OVCA1(DPH1, DPH2L1), BRCA1, BECN1, SLC9A3R1

On chromosome 18: EPB41L3, SMAD4 (ELAC1, DPC4), DCC

On chromosome 19: STK11 (LKB1)

On chromosome 22: SMARCB1 (BAF47, SNF5), RRP22, TMPRSS6, CHEK2 (CHK2, RAD53), NF2, PRR5





Affiliations:
InTextoResearch, 4 chemin de Hoevel, 4837 Baelen, Wallonie (Wallonia), Belgique (Belgium)
Laboratoire Jean-Claude Heuson de Cancérologie Mammaire, Institut Jules Bordet - Université Libre de Bruxelles (ULB), Bruxelles (Brussels), Belgique (Belgium)


Main Menu



Webmaster / Webmestre: Marc Lacroix
This page hosted by/Page hébergée par
Get your own Free Home Page /Obtenez votre page personnelle gratuite

Made in BELGIUM / WALLONIA / EUREGIO MAAS-RHINE - Fait en BELGIQUE / WALLONIE / EUREGIO MEUSE-RHIN - (Molecular breast cancer - Cancer du sein, aspects moléculaires) - Marc Lacroix & SciMedWeb® & InTextoResearch® 2007-2009